Scholarlink

<p>Discovering more targets is of great importance for developing alternative interventions for tumor therapy. The roles of transmembrane protein 175 (TMEM175) in neurodegeneration diseases have been reported, however its functions in tumor immune surveillance are not known. We show that TMEM175 conditional knockout in macrophages inhibits the tumor growth and metastasis through promoting the anti-tumor immunity in the tumor microenvironment (TME), including elevated M1-like polarization, reduced M2-like polarization, and facilitated recruitment and activation of T cells and nature killer cells (NKs). The anti-tumor immunity is abrogated by caspase-1 inhibitor VX-765, anti-IL-1β, and anti-IL-18. <i>Tmem175</i><sup><i>−/−</i></sup> bone marrow-derived macrophages (BMDMs) show enhanced tumor antigen cross-presentation that is further strengthened by IL-1β and IL-18. NLRP3 is robustly elicited in <i>Tmem175</i><sup><i>−/−</i></sup> BMDMs by the tumor cell debris through lysosomal permeabilization and cathepsin B leakage. Finally, <i>Tmem175</i><sup><i>−/−</i></sup> mice are more responsive to anti-PD-1. Our works implies TMEM175 to be a potential target for immunotherapy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Deficiency of lysosomal TMEM175 in myeloid macrophages exerts anti-tumor immunity via inflammasome and cross-presentation pathway

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月14日

查看全文
  • Ziqi Zhang,
  • Xue li,
  • Tianqi Lu,
  • Jingyun Yang,
  • Xuejiao Han,
  • Zhenfei Bi,
  • Jingwen Luo,
  • Aqu Alu,
  • Weiqi Hong,
  • Siyuan Chen,
  • Lei Chen,
  • Yuan Cheng,
  • Xuemei He,
  • Chenjing Zhu,
  • Manni Wang,
  • Qingfang Li,
  • Yang Wang,
  • Lu Li,
  • Hong Lei,
  • Jie Lan,
  • Jia Geng,
  • Yuquan Wei,
  • Xiawei Wei

摘要

Discovering more targets is of great importance for developing alternative interventions for tumor therapy. The roles of transmembrane protein 175 (TMEM175) in neurodegeneration diseases have been reported, however its functions in tumor immune surveillance are not known. We show that TMEM175 conditional knockout in macrophages inhibits the tumor growth and metastasis through promoting the anti-tumor immunity in the tumor microenvironment (TME), including elevated M1-like polarization, reduced M2-like polarization, and facilitated recruitment and activation of T cells and nature killer cells (NKs). The anti-tumor immunity is abrogated by caspase-1 inhibitor VX-765, anti-IL-1β, and anti-IL-18. Tmem175−/− bone marrow-derived macrophages (BMDMs) show enhanced tumor antigen cross-presentation that is further strengthened by IL-1β and IL-18. NLRP3 is robustly elicited in Tmem175−/− BMDMs by the tumor cell debris through lysosomal permeabilization and cathepsin B leakage. Finally, Tmem175−/− mice are more responsive to anti-PD-1. Our works implies TMEM175 to be a potential target for immunotherapy.